Loading...
Loading...
India's cephalexin imports from CYPRUS total $158 across 1 shipments from 1 foreign suppliers. REMEDICA LTD. leads with $158 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include SYNAPSE LABS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for cephalexin — a concentrated sourcing relationship with select suppliers from CYPRUS.

REMEDICA LTD. is the leading Cephalexin supplier from CYPRUS to India, with import value of $158 across 1 shipments. The top 5 suppliers — REMEDICA LTD. — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | REMEDICA LTD. | $158 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SYNAPSE LABS PRIVATE LIMITED | $158 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Cephalexin suppliers from CYPRUS to India include REMEDICA LTD.. The leading supplier is REMEDICA LTD. with import value of $158 USD across 1 shipments. India imported Cephalexin worth $158 USD from CYPRUS in total across 1 shipments.
India imported Cephalexin worth $158 USD from CYPRUS across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Cephalexin sourced from CYPRUS include SYNAPSE LABS PRIVATE LIMITED. The largest buyer is SYNAPSE LABS PRIVATE LIMITED with $158 in imports across 1 shipments.
The total value of Cephalexin imports from CYPRUS to India is $158 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists